Menu
🏆 ASCRS 2026 – Best Paper of Session Award
📍 Washington, DC, USA
In 2026, Dr. Iskender Alkin Solmaz and his team were honored with the Best Paper of Session Award at the Annual Meeting of the American Society of Cataract and Refractive Surgery (ASCRS) in Washington, DC.
Recognized as one of the most prestigious international meetings in ophthalmology, ASCRS brings together leading eye surgeons, researchers, and academic experts from around the world.
The award was presented in recognition of the scientific quality, innovation, and potential clinical impact of the research presented by Dr. Solmaz and his team.
For Dr. Solmaz, the award represents not only an academic achievement but also the culmination of years of clinical experience, scientific research, and international collaboration.
Dr. Iskender Alkin Solmaz is an ophthalmologist specializing in oculoplastic surgery, oculofacial surgery, eyelid surgery, blepharoplasty, and facial rejuvenation procedures.
Based in Istanbul, Türkiye, he treats patients not only from Türkiye but also from Europe, the Middle East, and North America.
Throughout his career, Dr. Solmaz has participated in more than 25,000 surgical procedures and medical interventions, combining extensive clinical experience with ongoing academic and scientific work.
In addition to his surgical practice, he regularly presents research at international scientific meetings and contributes to the advancement of ophthalmic innovation.
The recognition received at ASCRS 2026 reflects this commitment to both patient care and scientific excellence.
The American Society of Cataract and Refractive Surgery (ASCRS) is widely regarded as one of the world’s leading professional organizations in ophthalmology.
Founded in 1974, ASCRS hosts one of the largest and most respected annual scientific meetings in the field, bringing together thousands of ophthalmologists, researchers, and industry leaders.
Presenting research at ASCRS is considered a significant academic accomplishment.
Receiving a scientific award at the meeting represents an even higher level of recognition by international experts and peers.
The Best Paper of Session Award is granted to presentations that demonstrate exceptional scientific merit and potential impact on the future of ophthalmic care.
Dr. Solmaz believes that clinical practice and scientific research should go hand in hand.
Many of the advances that improve patient outcomes begin with research, innovation, and a commitment to understanding disease at a deeper level.
His approach has always been to combine real-world surgical experience with scientific investigation in order to contribute to the future of ophthalmic medicine.
The ASCRS award reflects this philosophy and reinforces the importance of integrating clinical expertise with academic achievement.
In addition to his clinical practice, Dr. Solmaz is one of the founders of TelomEYE Pharmaceuticals, a Canadian biotechnology company focused on developing innovative approaches for eye diseases.
Through ongoing research programs, international collaborations, and scientific initiatives, TelomEYE continues to explore next-generation therapeutic opportunities in ophthalmology.
The recognition received at ASCRS 2026 further highlights the growing international interest in the scientific work being conducted by Dr. Solmaz and his team.
Today’s patients increasingly value not only surgical expertise but also academic credibility and international recognition.
The award received at ASCRS 2026 reflects years of dedication to both clinical excellence and scientific advancement.
For international patients seeking highly specialized oculoplastic and oculofacial care, such achievements provide additional confidence that they are being treated by a surgeon actively contributing to the future of the field.
The ASCRS 2026 Best Paper of Session Award represents an important milestone in Dr. Solmaz’s professional and scientific journey.
Through continued research, international collaborations, scientific publications, and clinical innovation, Dr. Solmaz remains committed to advancing ophthalmic care while representing Turkish medicine on the global stage.
